CVS Corp (CVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 7,989,000 | 6,602,000 | 5,015,000 | 2,224,000 | 7,192,000 |
| Depreciation Amortization | 4,917,000 | 3,828,000 | 2,263,000 | 1,126,000 | 4,441,000 |
| Income taxes - deferred | -402,000 | -645,000 | -370,000 | -166,000 | -570,000 |
| Accounts receivable | -2,703,000 | -3,504,000 | -2,384,000 | -2,093,000 | -1,510,000 |
| Accounts payable and accrued liabilities | 2,898,000 | 3,973,000 | 1,702,000 | 576,000 | 2,769,000 |
| Other Working Capital | 3,857,000 | 3,766,000 | 1,599,000 | -379,000 | 3,159,000 |
| Other Operating Activity | 1,709,000 | 240,000 | 914,000 | 1,604,000 | 384,000 |
| Operating Cash Flow | $18,265,000 | $14,260,000 | $8,739,000 | $2,892,000 | $15,865,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -9,963,000 | N/A | -5,570,000 | -954,000 | -9,639,000 |
| PPE Investments | -2,520,000 | -1,923,000 | -1,315,000 | -829,000 | -2,437,000 |
| Net Acquisitions | -146,000 | -135,000 | -108,000 | -84,000 | -26,000 |
| Purchase Of Investment | N/A | -7,417,000 | N/A | N/A | N/A |
| Sale Of Investment | 7,246,000 | 5,559,000 | 3,947,000 | N/A | 6,467,000 |
| Other Investing Activity | 122,000 | 95,000 | 72,000 | 0 | 101,000 |
| Investing Cash Flow | $-5,261,000 | $-3,821,000 | $-2,974,000 | $-1,867,000 | $-5,534,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 252,000 | N/A |
| Debt Issued | 987,000 | 987,000 | N/A | N/A | 9,958,000 |
| Debt Repayment | -10,254,000 | -7,823,000 | -5,423,000 | -3,049,000 | -15,631,000 |
| Common Stock Issued | 549,000 | 440,000 | 330,000 | 212,000 | 264,000 |
| Dividend Paid | -2,625,000 | -1,965,000 | -1,306,000 | -656,000 | -2,624,000 |
| Other Financing Activity | -13,000 | -81,000 | -113,000 | 56,000 | 337,000 |
| Financing Cash Flow | $-11,356,000 | $-8,442,000 | $-6,512,000 | $-3,185,000 | $-7,696,000 |
| Beginning Cash Position | 11,043,000 | 11,043,000 | 11,043,000 | 11,043,000 | 8,408,000 |
| End Cash Position | 12,691,000 | 13,040,000 | 10,296,000 | 8,883,000 | 11,043,000 |
| Net Cash Flow | $1,648,000 | $1,997,000 | $-747,000 | $-2,160,000 | $2,635,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 18,265,000 | 14,260,000 | 8,739,000 | 2,892,000 | 15,865,000 |
| Capital Expenditure | -2,520,000 | -1,923,000 | -1,315,000 | -829,000 | -2,437,000 |
| Free Cash Flow | 15,745,000 | 12,337,000 | 7,424,000 | 2,063,000 | 13,428,000 |